Welcome to MyStrategist, an online experience like no other in the medical device industry.

MedTech Strategist Market Pathways explores the people, challenges, and opportunities impacting the medtech regulatory and reimbursement community. Explore our coverage. Think Strategically. Subscribe Today .

Browse   Latest Issue

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Regulatory & Reimbursement

CMS Mandatory ESRD Model Looks to Accelerate Home Dialysis and Kidney Transplants

The agency’s End-Stage Renal Disease Treatment Choices (ETC) Model, set to launch January 1, will impact approximately 30% of kidney care providers for an estimated $23 million cost savings over the next few years. David White of the American Society of Nephrology discusses the model’s positives and challenges, particularly with the added impact of COVID-19.

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Virtual Investment & Partnering Summit 2020 registration is now open. On-Demand October 15th – November 20th this year's most anticipated global event will sell out. Register Today!

Register   Learn More
Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review


Regulatory & Reimbursement

CMS Mandatory ESRD Model Looks to Accelerate Home Dialysis and Kidney Transplants

The agency’s End-Stage Renal Disease Treatment Choices (ETC) Model, set to launch January 1, will impact approximately 30% of kidney care providers for an estimated $23 million cost savings over the next few years. David White of the American Society of Nephrology discusses the model’s positives and challenges, particularly with the added impact of COVID-19.

Discover the people, technologies, and companies in the global medical device industry that will impact your corporate strategy with MedTech Strategist.

Subscribe Now   Learn More
More From Market Pathways:

FEMA Wants to Collaborate with Device Sector on Pandemic Supply Chain, but Industry has Concerns

For the first time, the US Federal Emergency Management Agency is requesting assistance from the private sector, including medical device manufacturers and distributors, in addressing critical healthcare resource supply chain and distribution challenges in light of the shortfalls experienced during the COVID-19 health crisis, and to prepare for potential future pandemics. Among the issues is the level of transparent collaboration and data-sharing that is being requested from participants.

Read Article